The Bone Marrow and Stem Cell Transplant Program at Weill Cornell Medicine is dedicated to providing the best care and the most innovative research in a compassionate and comfortable environment.
We utilize a multidisciplinary approach for patients with cancer and blood diseases in need of stem cell transplant, providing world-class clinical care and collaboration with experts in leukemia, lymphoma, myeloma and other blood disorders. Based in NewYork-Presbyterian Hospital, one of the top ten general hospitals in the nation, the expertise of our consulting team is unsurpassed.
Our patients and families cope with life-threatening illness, and sensitivity and compassion are a priority for our team. We view each patient as an individual, and our approach ensures that each treatment regimen is narrowly tailored to meet the unique, changing needs of our patients and their families – before, during and after transplant.
As New York’s premier healthcare network, Weill Cornell Medicine is at the forefront of scientific research and clinical trials, enabling us to provide a full range of diagnostic and treatment protocols, including the latest breakthroughs in medicine.
Our team of internationally recognized bone marrow and stem cell transplant specialists is known for advanced work and published research in:
- Treating patients with aggressive leukemia and myelodysplastic syndromes
- Bridge protocols for patients with refractory lymphoma and leukemia
- Novel strategies to mobilize stem cells and improve transplantation for patients with multiple myeloma, leukemia and lymphoma
- Transplants for solid tumors, severe auto-immune disorders, and AIDS
We pride ourselves on exceptional outcomes and offer patients the most advanced diagnostic methods and treatment therapies to improve quality of life, including:
- Umbilical cord blood transplant
- Outpatient transplant
- Autologous and allogeneic bone marrow and peripheral blood stem cell transplantation
- Matched unrelated donor stem cell transplantation through the National Donor Matching Program
- Non-ablative "mini" transplants
- Haplo Cord Transplant, allowing us to find donors for all, regardless of age or ethnic background
- Bendamustine, a therapy that is well-tolerated and has excellent response rates in patients with myeloma
- Novel forms of transplant, offering hope and success to older patients with leukemia
Learn more about our treatment offerings by visiting www.cornellbmt.org.
Clinical trials are important to improve outcomes and offer new treatment options. At Weill Cornell Medicine, we conduct more studies in blood cancers than any of our regional peers, allowing us to provide our patients with access to many multi-phase clinical trials. As active members of the international cancer research community, our oncologists also collaborate with other research centers to offer patients the most promising treatments available.
In concert with your referring physician, we are always available to offer a second opinion in the form of a consultation with one of our specialists.
Why Choose Us?
Our collaborative approach provides supportive, comprehensive care alongside the most cutting-edge medical treatments. This enables patients to receive the best possible transplant outcomes. Additionally, we offer more allogeneic transplants for older adults than any other center in the tri-state area.
For more information or to schedule an appointment, call us at 212-746-2119 or 212-746-2646.
Weill Cornell Medical College is ranked among the nation’s best by U.S. News & World Report year after year